21 May 2009
Cell-saver application in blood salvage during orthotopic liver transplantation
R Król, J Pawlicki, J Ziaja, L CierpkaAnn Transplant 2009; 14(1): 41-41 :: ID: 880346
Abstract
Background: Increased intra-operative blood loss during orthotropic liver
transplantation (OLTx) is often observed after introduction of the OLTx
programme. Massive transfusions increase the risk of early complications after OLTx and decrease liver graft survival. The aim of the study is retrospective analysis of the blood loss during OLTx and advantages of cell-saver application in blood salvage from the operative field.
Material/Methods: 41 of 46 OLTx operations performed between 2005 and 2008 at the department were analysed. Three patients who died in early postoperative period due to non-haemorrhagic reasons and 1 patient who required re-transplantation were excluded. Blood loss was estimated by measuring the volume of blood regained from the liquid aspirated from the operative field.
Results: Mean amount of blood regained from operative field was 1922.2±922.2 ml. Its mean hematocrite was 46.14±7.31%. Mean amount of blood transfused during operation was 6.1±3.2 units. Two patients died due to overlapping massive blood loss and post-reperfusion injury. There were no severe early complications in analysed group except 3 cases of acute rejection treated successfully with steroids.
Conclusions: Cell saver allows reducing significantly the amount of transfused blood during OLTx operation, what is particularly important in the early period after introduction of the programme.
Keywords: Liver Transplantation
In Press
Original article
CD146⁺ Endothelial Cells Facilitate Renal Interstitial Fibrosis Through Endothelial-to-Mesenchymal TransitionAnn Transplant In Press; DOI: 10.12659/AOT.945917
Original article
Effect of Medical Accessibility on Long-Term Survival in Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.944839
Most Viewed Current Articles
05 Apr 2022 : Original article 13,217
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,665
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,806
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,520
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860